Cannabis and Pathogenic Mechanisms influencing Blood Brain Barrier Function in HIV
大麻和影响艾滋病毒血脑屏障功能的致病机制
基本信息
- 批准号:10683027
- 负责人:
- 金额:$ 124.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-15 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAdhesionsAdverse effectsAffectAgonistAnti-Inflammatory AgentsAstrocytesBiological MarkersBiologyBloodBlood - brain barrier anatomyBrainCannabidiolCannabinoidsCannabisCardiovascular DiseasesCell Adhesion MoleculesCellsCentral Nervous SystemCerebrospinal FluidChronicClinicalCognition DisordersCytoskeletonDNADataDiffusion Magnetic Resonance ImagingDoseEndocannabinoidsEndothelial CellsEndotheliumEtiologyExtravasationFrequenciesFutureGene ExpressionGeneral PopulationHIVHIV InfectionsHomeostasisImageIn VitroIndividualIndividual DifferencesInfectionInflammationInflammation MediatorsInflammatoryInjuryInterdisciplinary StudyInvestigationLeukocytesLinkMacrophageMeasuresMetabolicMicrofluidicsMicrogliaMitochondriaModelingMood DisordersNervous System TraumaNeurocognitiveNeurocognitive DeficitNeurogliaNeuronsNeurotoxinsObservational StudyOutcomeOxidative PhosphorylationParticipantPathogenesisPathogenicityPatientsPatternPericytesPermeabilityPersonsPharmaceutical PreparationsPlantsPlasmaPre-Clinical ModelPropertyProteinsPublic HealthRNAResearchResearch ProposalsRiskRoleRouteStructureSubstance abuse problemTechniquesTechnologyTestingTetrahydrocannabinolTherapeutic InterventionTight JunctionsToxic effectVariantViralVirus ReplicationVulnerable Populationsantagonistantiretroviral therapybiomarker panelblood-brain barrier functionblood-brain barrier permeabilizationcannabinoid receptorcannabis use behaviorcohortimaging modalityimprovedin vitro Modelin vivoinflammatory milieuinnovationinsightknowledge translationmarijuana usemigrationmitochondrial dysfunctionmonocytemultidisciplinarymultimodalityneuroimagingnovel therapeuticspre-clinicalreceptor bindingrecruitresearch clinical testingresponsesubstance use
项目摘要
People with HIV (PWH) remain vulnerable to central nervous system complications (e.g., neurocognitive
impairment) despite antiretroviral therapy (ART) that suppresses viral replication. While many etiologies of these
complications exist, damage to the blood-brain-barrier (BBB), inflammation, and mitochondrial dysfunction are
consistently implicated, yet seldom studied simultaneously. PWH also use cannabis more frequently than the
general population and recent evidence by our group and others indicates that cannabis may protect PWH from
BBB damage by reducing inflammation and promoting mitochondrial homeostasis. The proposed
multidisciplinary, translational project will combine a clinical observational study with two preclinical models: a)
a technologically advanced brain chip model for BBB and b) personalized ex vivo/in vitro modeling of
mitochondrial toxicity in BBB cells to determine the effects of cannabis use on the BBB in PWH. Using this
multilevel approach, we will test the hypothesis that cannabis effects on the BBB vary based on patterns of use:
moderate use will be associated with beneficial effects, due to the anti-inflammatory properties of cannabis, but
chronic daily use will have detrimental effects. In a cohort of PWH and people without HIV (PWoH) across a
range of cannabis use from naïve to daily users, we will measure in plasma and cerebrospinal fluid (CSF) a
panel of biomarkers that reflect the BBB, inflammation, and mitochondrial dysfunction. These readouts will be
correlated with advanced permeability and multicompartment diffusion magnetic resonance imaging that will
identify global and regional variations in BBB leakage along with neuronal and glial microstructural properties
(Aim 1). We will model the BBB using 3D microfluidic cultures of brain endothelial and parenchymal cell subsets
to measure the effects of HIV and cannabinoids on BBB permeability, inflammatory gene expression, and
markers of mitochondrial function (Aim 2). Because responses to HIV and cannabis are often specific to
individuals or groups of individuals, we will use monocyte-derived macrophages and sera from the PWH and
PWoH in the observational study to determine the effects of cannabis (and HIV) on BBB cellular components
(astrocytes and endothelial cells), and on mitochondrial function, inflammatory gene expression, and BBB
biomarker gene expression (Aim 3). Thus, the proposed project will provide innovative clinical readouts in a
unique cohort alongside state-of-the-art modeling of the BBB and personalized investigation of pathogenic
mechanisms. This highly innovative, multidisciplinary research proposal is very likely to generate impactful
translational knowledge regarding mechanisms of pathogenesis and guide future therapeutic interventions. With
our combined clinical and pre-clinical expertise in HIV infection, substance abuse, BBB biology and imaging, and
mitochondrial homeostasis, we are uniquely suited to perform the proposed research.
艾滋病毒携带者(PWH)仍然容易出现中枢神经系统并发症(例如,神经认知
损害),尽管抗逆转录病毒治疗(ART)抑制病毒复制。虽然这些疾病的许多病因
存在并发症,血脑屏障(BBB)受损,炎症和线粒体功能障碍
始终如一地牵涉其中,但很少同时研究。威尔斯亲王使用大麻的频率也比
普通人群以及我们小组和其他人最近的证据表明,大麻可能会保护威尔斯亲王免受
通过减少炎症和促进线粒体动态平衡来破坏血脑屏障。建议数
多学科、转化性项目将结合临床观察性研究和两个临床前模型:a)
用于血脑屏障的技术先进的脑芯片模型和b)个性化的体外/体外建模
确定大麻使用对PWH患者血脑屏障的影响。使用这个
通过多层次的方法,我们将检验大麻对血脑屏障的影响根据使用模式的不同而变化的假设:
由于大麻的抗炎特性,适量使用将产生有益的效果,但
长期的日常使用会产生有害的影响。在威斯康星医院和没有感染艾滋病毒(PWoH)的人群中
大麻的使用范围从幼稚到日常使用,我们将测量血浆和脑脊液(CSF)中的a
反映血脑屏障、炎症和线粒体功能障碍的一组生物标志物。这些读数将是
与先进的渗透率和多间隔扩散磁共振成像相关,将
确定血脑屏障渗漏的全球和区域差异以及神经元和神经胶质的微结构特征
(目标1)。我们将使用脑内皮细胞和实质细胞亚群的3D微流控培养来模拟血脑屏障
目的:检测HIV和大麻素对血脑屏障通透性、炎症基因表达和
线粒体功能标记物(目标2)。因为对艾滋病毒和大麻的反应通常是针对
个人或个人团体,我们将使用来自威尔斯亲王医院的单核细胞来源的巨噬细胞和血清以及
PWoH在观察性研究中确定大麻(和艾滋病毒)对血脑屏障细胞成分的影响
(星形胶质细胞和内皮细胞),以及线粒体功能、炎症基因表达和血脑屏障
生物标记物基因表达(AIM 3)。因此,拟议的项目将在
独特的队列,以及最先进的血脑屏障建模和个性化的病因调查
机制。这一高度创新、多学科的研究提案很可能会产生
关于发病机制的翻译知识,并指导未来的治疗干预。使用
我们在HIV感染、药物滥用、血脑屏障生物学和成像方面的临床和临床前综合专业知识,以及
由于线粒体的动态平衡,我们非常适合进行这项拟议的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jerel Adam Fields其他文献
Caloric restriction mimetic 2-deoxyglucose alters metabolic and transcriptomic phenotype in association with changes in chromatin accessibility in human astrocytes
热量限制模拟物 2-脱氧葡萄糖改变了人类星形胶质细胞的代谢和转录组表型,并与染色质可及性的变化相关联
- DOI:
10.1038/s41598-025-03796-w - 发表时间:
2025-06-03 - 期刊:
- 影响因子:3.900
- 作者:
Matthew Spencer;Jacqueline R. Kulbe;Vikram Venkatesh;Anna Laird;Mary Ford;Sydney O’Brien;Ali Boustani;Johannes C. M. Schlachetzki;Jerel Adam Fields - 通讯作者:
Jerel Adam Fields
231. Effects of Tenofovir Alafenamide Fumarate on Inflammatory Markers and Behavior in gp120 Mice
- DOI:
10.1016/j.biopsych.2023.02.471 - 发表时间:
2023-05-01 - 期刊:
- 影响因子:
- 作者:
Jacqueline Kulbe;Mary Swinton;Anh Le;Anna Laird;Nicholas Scrivens;Michael Mante;Jazmin Florio;Robert Rissman;Jerel Adam Fields - 通讯作者:
Jerel Adam Fields
Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management
HIV 相关认知功能障碍的潜在机制及其治疗管理的新兴疗法
- DOI:
10.1038/s41582-023-00879-y - 发表时间:
2023-10-10 - 期刊:
- 影响因子:33.100
- 作者:
Ronald J. Ellis;María J. Marquine;Marcus Kaul;Jerel Adam Fields;Johannes C. M. Schlachetzki - 通讯作者:
Johannes C. M. Schlachetzki
Correction: GP120 and tenofovir alafenamide alter cannabinoid receptor 1 expression in hippocampus of mice
更正:GP120 和替诺福韦阿拉芬酰胺改变小鼠海马中大麻素受体 1 的表达
- DOI:
10.1007/s13365-023-01192-6 - 发表时间:
2024-01-04 - 期刊:
- 影响因子:1.900
- 作者:
Jacqueline Renee Kulbe;Alexandra Anh Le;Michael Mante;Jazmin Florio;Anna Elizabeth Laird;Mary K. Swinton;Robert A. Rissman;Jerel Adam Fields - 通讯作者:
Jerel Adam Fields
Jerel Adam Fields的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jerel Adam Fields', 18)}}的其他基金
The role of TFAM alterations in HIV- and ART-induced mitochondrial dysfunction in the brain
TFAM 改变在 HIV 和 ART 诱导的大脑线粒体功能障碍中的作用
- 批准号:
10536678 - 财政年份:2022
- 资助金额:
$ 124.27万 - 项目类别:
Astoglial reactivity and metabolism in aging people with HIV
老年艾滋病毒感染者的星形胶质细胞反应性和代谢
- 批准号:
10846438 - 财政年份:2022
- 资助金额:
$ 124.27万 - 项目类别:
The role of TFAM alterations in HIV- and ART-induced mitochondrial dysfunction in the brain
TFAM 改变在 HIV 和 ART 诱导的大脑线粒体功能障碍中的作用
- 批准号:
10403383 - 财政年份:2022
- 资助金额:
$ 124.27万 - 项目类别:
Mechanisms of mitochondrial fission/fusion dysregulation during HIV-1-associated
HIV-1相关期间线粒体裂变/融合失调的机制
- 批准号:
8542439 - 财政年份:2013
- 资助金额:
$ 124.27万 - 项目类别:
Mechanisms of mitochondrial fission/fusion dysregulation during HIV-1-associated
HIV-1相关期间线粒体裂变/融合失调的机制
- 批准号:
8652197 - 财政年份:2013
- 资助金额:
$ 124.27万 - 项目类别:
Regulation of Astrocyte TIMP-1 in HIV-Associated Dementia
星形胶质细胞 TIMP-1 在 HIV 相关痴呆中的调节
- 批准号:
8141024 - 财政年份:2011
- 资助金额:
$ 124.27万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 124.27万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 124.27万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 124.27万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 124.27万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 124.27万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 124.27万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 124.27万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 124.27万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 124.27万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 124.27万 - 项目类别:














{{item.name}}会员




